The Animal Models and Behavioral Testing Core will provide the expertise, personnel and resources necessary to perform a variety of in vivo tests in rats and mice to enhance and extend research on drugs of abuse, addiction and HIV. The personnel in this Core have combined experience in a wide range of behavioral procedures. These include rodent models of drug reward, drug seeking, self-administration and relapse, tests of anxiety-like and depression-like behaviors, models of stress, measurements of several aspects of rodent activity, assessment of anhedonia, and tests for learning, memory and cognitive function. A former goal of the Animal Core, and now of the Animal Models and Behavioral Testing Core, is to support the breeding of mouse lines important to the research of members of the Center and the community at large. Examples of mice bred in our facility include opioid receptor, cannabinoid receptor, and chemokine receptor and ligand knockout mice. Breeding the mice in a central facility enhances the cost-effectiveness of using these mouse models and encourages sharing of data on multiple endpoints from a single mouse line. The Core Director, Dr. Unterwald, and Co-Investigators, Drs. Lynn Kirby and Sara Ward, have extensive experience with all of the endpoints and techniques supported by the Animal Models and Behavioral Testing Core (see biosketches). They will work together with investigators who wish to assess these measures in relationship to drugs of abuse, potential therapeutics, HIV, pain, and other manipulations. The overall aim of the Animal Models and Behavioral Testing Core is to provide state-of-the-art analysis of behaviors in a variety of animal models. Because of their expertise, the key personnel of the Core will work with investigators to design studies and develop new rodent models as research questions arise. They will assist investigators with the development of animal models and provide analysis of behavioral phenotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA013429-19
Application #
9460480
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
19
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Ward, Sara Jane; Castelli, Francesca; Reichenbach, Zachary W et al. (2018) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sci 195:1-5
Liu, Jeffrey J; Sharma, Kirti; Zangrandi, Luca et al. (2018) In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360:
Oliver, Chicora F; Simmons, Steven J; Nayak, Sunil U et al. (2018) Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75-79
Zewde, Ashenafi Mebratu; Yu, Frances; Nayak, Sunil et al. (2018) PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects. J Neurosci Methods 293:284-288
Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L et al. (2018) Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation. J Neuroinflammation 15:25
Ramirez, Servio H; Andrews, Allison M; Paul, Debayon et al. (2018) Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. Fluids Barriers CNS 15:19
Brailoiu, Eugen; Barlow, Christine L; Ramirez, Servio H et al. (2018) Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. Neuroscience 377:105-113
Barbe, Mary F; Massicotte, Vicky S; Assari, Soroush et al. (2018) Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism. Bone 110:267-283
Gentile, Taylor A; Simmons, Steven J; Barker, David J et al. (2018) Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol 23:247-255
Hicks, Callum; Huang, Peng; Ramos, Linnet et al. (2018) Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats. ACS Chem Neurosci 9:1327-1337

Showing the most recent 10 out of 343 publications